PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

September 1, 2025

Conditions
Gastric CancerPeritoneal Carcinomatosis
Interventions
DRUG

Combined Doxorubicin and Cisplatin Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic FOLFOX chemotherapy

Each course of combined treatment will start with PIPAC (a pressurized aerosol containing cisplatin 10.5 mg/m2 and doxorubicin 2.1 mg/m2 diluted in NaCl 0.9% applied through the nebulizer inside the abdominal cavity during laparoscopy). Fourteen days afterward 2 cycles of systemic FOLFOX chemotherapy will be applied within 28 days. The interval between combined treatment courses will be 14 days.

Trial Locations (2)

08406

Nationa Cancer Institute, Vilnius

08661

Vilnius University hospital Santaros Klinikos, Vilnius

All Listed Sponsors
collaborator

Vilnius University Hospital Santaros Klinikos

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Vilnius University

OTHER